Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Selective suppression of Th1 cytokine production with TAK-603

Oct. 21, 1997

U.S. testing of Toyama antiarthritic to begin soon

Oct. 20, 1997

BASF prepares anti-hTNF-alpha antibodies

Oct. 20, 1997

Prodrugs of selective COX-2 inhibitors

Oct. 20, 1997

P&G develops dihydrobenzofuran compounds for inflammation

Oct. 17, 1997

COX-2 inhibitors from Chugai

Oct. 17, 1997

New antiarthritic agents described by Procter & Gamble

Oct. 15, 1997

Verigen licenses Italian rights to anti-TNF-alpha product

Oct. 14, 1997

Eltenac efficacy demonstrated in osteoarthritis

Oct. 13, 1997

FDA grant awarded for research on Dupuytren's disease therapy

Oct. 8, 1997

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...